JAGX
Jaguar Health Inc
Price:  
7.77 
USD
Volume:  
125,300.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

JAGX WACC - Weighted Average Cost of Capital

The WACC of Jaguar Health Inc (JAGX) is 4.3%.

The Cost of Equity of Jaguar Health Inc (JAGX) is 6.25%.
The Cost of Debt of Jaguar Health Inc (JAGX) is 5.50%.

Range Selected
Cost of equity 5.40% - 7.10% 6.25%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 4.00% - 7.00% 5.50%
WACC 3.3% - 5.4% 4.3%
WACC

JAGX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.33 0.4
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.40% 7.10%
Tax rate 26.20% 27.00%
Debt/Equity ratio 6.23 6.23
Cost of debt 4.00% 7.00%
After-tax WACC 3.3% 5.4%
Selected WACC 4.3%

JAGX's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for JAGX:

cost_of_equity (6.25%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.33) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.